The metabolic deterioration that antedates diabetes: Personal trajectories of HbA1c and fasting glucose as early indicators and possible triggers for intervention

Diabetes/Metabolism Research and Reviews

Volumn 29, Issue 1, 2013, Pages 1-7

  Dankner, Rachel ^a,b,c   Bergman, Michael ^d   Danoff, Ann ^d   Qureshi, Sana ^c   Whitford, Ian ^c   Kaviani, Nargess ^e   Dynkevich, Yevgeniya ^e   Roth, Jesse ^c,f,g  

^a GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Yeshiva University ^*  (United States)

^f DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Blood glucose; C peptide; Dysglycemia; Glycation gap; Glycemia level; Hemoglobin A1c; Hyperglycemia; Personalized HbA1c; Prediabetes; Type 2 diabetes

Indexed keywords

GLUCOKINASE; GLUCOSE; HEMOGLOBIN A1C; METFORMIN;

AFRICAN AMERICAN; ALZHEIMER DISEASE; BEHAVIOR THERAPY; BLOOD GLUCOSE MONITORING; CLINICAL EFFECTIVENESS; CONSENSUS; DEPRESSION; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DYSGLYCEMIA; EARLY INTERVENTION; ENVIRONMENTAL FACTOR; ETHNICITY; GENOME ANALYSIS; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBINOPATHY; HUMAN; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; HYPOTHYROIDISM; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; IRON DEFICIENCY ANEMIA; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PERSONALIZED MEDICINE; POPULATION RESEARCH; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; EARLY DIAGNOSIS; FASTING; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; PREDIABETIC STATE;

EID: 84872240088     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2373     Document Type: Review

References (89)

1. Gawande A. 2007. Better: a surgeon's notes on performance. Metropolitan Books, Henry Holt and Company, New York.
2. Dankner R, Danoff A, Roth J. Can 'personalized diagnostics' promote earlier intervention for dysglycaemia? Hypothesis ready for testing. Diabetes Metab Res Rev 2010; 26: 7-9.
3. Shanik MH, Xu Y, Skrha J, Dankner R, Zick Y, Roth J. Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse? Diabetes Care 2008; 31(Suppl 2): S262-268.
4. Dankner R, Roth J. Predicting diabetes. In Prevention of Type 2 Diabetes, LeRoith D (ed). Springer: New York, 2012; 81-102.
5. Dankner R, Chetrit A, Shanik MH, Raz I, Roth J. Basal-state hyperinsulinemia in healthy normoglycemic adults is predictive of type 2 diabetes over a 24-year follow-up: a preliminary report. Diabetes Care 2009; 32: 1464-1466.
6. Roth J, Qiang X, Marban SL, Redelt H, Lowell BC. The obesity pandemic: where have we been and where are we going? Obes Res 2004; 12(Suppl 2): 88S-101S.
7. Novak V, Zhao P, Manor B, et al. Adhesion molecules, altered vasoreactivity, and brain atrophy in type 2 diabetes. Diabetes Care 2011; 34: 2438-2441.
8. Kurra S, Siris E. Diabetes and bone health: the relationship between diabetes and osteoporosis-associated fractures. Diabetes Metab Res Rev 2011; 27: 430-435.
9. Chowdhry MF, Vohra HA, Galinanes M. Diabetes increases apoptosis and necrosis in both ischemic and nonischemic human myocardium: role of caspases and poly-adenosine diphosphate-ribose polymerase. J Thorac Cardiovasc Surg 2007; 134: 124-131, 131 e121-123.
10. van Elderen SG, de Roos A, de Craen AJ, et al. Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up. Neurology 2010; 75: 997-1002.
11. Oumeish OY. Skin disorders in patients with diabetes. Clin Dermatol 2008; 26: 235-242.
12. Malecki MT. Genetics of type 2 diabetes mellitus. Diabetes Res Clin Pract 2005; 68(Suppl1): S10-S21.
13. Qi L, Hu FB, Hu G. Genes, environment, and interactions in prevention of type 2 diabetes: a focus on physical activity and lifestyle changes. Curr Mol Med 2008; 8: 519-532.
14. Hivert MF, Jablonski KA, Perreault L, et al. Updated genetic score based on 34 confirmed type 2 diabetes loci is associated with diabetes incidence and regression to normoglycemia in the Diabetes Prevention Program. Diabetes 2011; 60: 1340-1348.
15. Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010; 362: 800-811.
16. Mata-Cases M, De Prado-Lacueva C, Salido-Valencia V, et al. Incidence of complications and mortality in a type 2 diabetes patient cohort study followed up from diagnosis in a primary healthcare centre. Int J Clin Pract 2011; 65: 299-307.
17. Tirosh A, Shai I, Tekes-Manova D, et al. Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med 2005; 353: 1454-1462.
18. Perreault L, Pan Q, Mather KJ, et al. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet 2012; 379: 2243-2251.
19. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
20. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
21. Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB. A new look at screening and diagnosing diabetes mellitus. J Clin Endocr Metab 2008; 93: 2447-2453.
22. 1C assay in the diagnosis of diabetes. Diabetes Care 2009; 32: 1327-1334.
23. 1C. Diabetes Care 2011; 34(Suppl 2): S184-190.
24. Selvin E, Crainiceanu CM, Brancati FL, Coresh J. Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med 2007; 167: 1545-1551.
25. 1c for diabetes diagnosis. Diabetes Res Clin Pract 2011; 93: 310-311.
26. (1c) in the management of diabetes. J Diabetes 2009; 1: 9-17.
27. 1c: teaching a new dog old tricks. Ann Intern Med 2010; 152: 815-817.
28. American Diabetes Association. Standards of medical care in diabetes - 2010. Diabetes Care 2010; 33(Suppl 1): S11-61.
29. Colagiuri S, Borch-Johnsen K. DETECT-2: early detection of type 2 diabetes and IGT. Diabetes Voice 2003; 48: 11-13.
30. Colagiuri S, Lee CM, Wong TY, et al. Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes. Diabetes Care 2011; 34: 145-150.
31. 1c as a diagnostic tool for diabetes screening and new-onset diabetes prediction: a 6-year community-based prospective study. Diabetes Care 2011; 34: 944-949.
32. 1c is a strong predictor of type 2 diabetes in the general population. Diabetes Care 2011; 34: 1038-1040.
33. 1C and fasting glucose criteria to diagnose diabetes among US adults. Diabetes Care 2010; 33: 95-97.
34. 1C-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups. Diabetes Care 2010; 33: 580-582.
35. Lorenzo C, Haffner SM. Performance characteristics of the new definition of diabetes: the insulin resistance atherosclerosis study. Diabetes Care 2010; 33: 335-337.
36. 1C-based diagnostic criteria. Diabetes Care 2010; 33: 2184-2189.
37. 1c and glucose criteria identify different subjects as having type 2 diabetes in middle-aged and older populations: the KORA S4/F4 Study. Ann Med 2012; 44: 170-177.
38. 1C for diagnosing diabetes mellitus. Am J Med 2011; 124: 395-401.
39. 1C as a diagnostic criteria for diabetes in low- and middle-income settings: evidence from Peru. PLoS One 2011; 6: e18069.
40. 1C criteria in the US population in 1988-2006. Diabetes Care 2010; 33: 562-568.
41. 1C for the classification and prediction of diabetes. Diabetes Care 2011; 34: 84-89.
42. 1c. J Clin Endocrinol Metab 2010; 95: 5289-5295.
43. 1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2006; 29: 1619-1625.
44. 1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Care 2010; 33: 2104-2109.
45. (1c) for diagnosing prediabetes and diabetes in obese children and adolescents. Diabetes Care 2011; 34: 1306-1311.
46. 1C screening criterion on the diagnosis of pre-diabetes among US adults. Diabetes Care 2010; 33: 2190-2195.
47. 1C independent of mean blood glucose in children with type 1 diabetes. Diabetes Care 2010; 33: 1025-1027.
48. 1c and fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy. Diabetes Care 2003; 26: 163-167.
49. 1c 5.7-6.4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study. Lancet 2011; 378: 147-155.
50. 1c and fasting plasma glucose in population-based prediabetes screening. J Diabetes 2012.
51. 1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the US population: implications for diabetes diagnostic thresholds. Diabetes Care 2009; 32: 2027-2032.
52. Khaw KT, Wareham N, Luben R, et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ 2001; 322: 15-18.
53. Saito T, Watanabe M, Nishida J. Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: a randomized controlled trial. Arch Intern Med 2011; 171: 1352-1360.
54. 1C levels in women with type 1 diabetes. Diabetes Care 2007; 30: 1579-1580.
55. 1c in nondiabetic patients. Acta Haematol 2004; 112: 126-128.
56. 1c in type 1 diabetes mellitus. Pediatr Int 1999; 41: 357-362.
57. 1C but not serum glycated albumin is elevated in late pregnancy owing to iron deficiency. Diabetes Care 2008; 31: 1945-1948.
58. 1c assays. Clin Chim Acta 2006; 372: 206-209.
59. Proto G, De Marchi S, Cecchin E. Glycosylated hemoglobin in chronic alcoholics. Drug Alcohol Depend 1983; 12: 299-302.
60. 1c: is it the same in both hemispheres? J Diabetes Sci Technol 2009; 3: 668-671.
61. 1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care 2007; 30: 2453-2457.
62. 1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004. Diabetes Care 2008; 31: 1991-1996.
63. 1c). Diabet Med 2008; 25: 239-240.
64. 1c) in iron- and vitamin B12 deficiency. J Intern Med 1990; 227: 133-136.
65. Willekens FL, Roerdinkholder-Stoelwinder B, Groenen-Dopp YA, et al. Hemoglobin loss from erythrocytes in vivo results from spleen-facilitated vesiculation. Blood 2003; 101: 747-751.
66. Schnedl WJ, Wallner SJ, Piswanger C, Krause R, Lipp RW. Glycated hemoglobin and liver disease in diabetes mellitus. Wien Med Wochenschr 2005; 155: 411-415.
67. 1c caused by use of dapsone. Endocr Pract 2002; 8: 370-372.
68. Diop ME, Bastard JP, Meunier N, et al. Inappropriately low glycated hemoglobin values and hemolysis in HIV-infected patients. AIDS Res Hum Retroviruses 2006; 22: 1242-1247.
69. 1c associated with treatment with ribavirin. BMJ 2008; 336: 505.
70. Bernstein RM, Freedman DB, Liyanage SP, Dandona P. Glycosylated haemoglobin in rheumatoid arthritis. Ann Rheum Dis 1982; 41: 604-606.
71. (1c) measurement. Diabetes Care 2000; 23: 1197-1198.
72. Rubinow KB, Hirsch IB. Reexamining metrics for glucose control. JAMA 2011; 305: 1132-1133.
73. 1c in nondiabetic twins. Diabetes Care 2006; 29: 1739-1743.
74. Ferrannini E, Nannipieri M, Williams K, Gonzales C, Haffner SM, Stern MP. Mode of onset of type 2 diabetes from normal or impaired glucose tolerance. Diabetes 2004; 53: 160-165.
75. Tabak AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimaki M, Witte DR. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 2009; 373: 2215-2221.
76. Mason CC, Hanson RL, Knowler WC. Progression to type 2 diabetes characterized by moderate then rapid glucose increases. Diabetes 2007; 56: 2054-2061.
77. 1c and fasting plasma glucose levels during the development of type 2 diabetes: the Toranomon Hospital Health Management Center Study 7 (TOPICS 7). Diabetes Care 2012; 35: 1050-1052.
78. Sabanayagam C, Liew G, Tai ES, et al. Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes? Diabetologia 2009; 52: 1279-1289.
79. Wong TY, Liew G, Tapp RJ, et al. Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies. Lancet 2008; 371: 736-743.
80. Bergman M. Inadequacies of absolute threshold levels for diagnosing prediabetes. Diabetes Metab Res Rev 2010; 26: 3-6.
81. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
82. Roth J, Whitford I, Dankner R, Szulc AL. How the immunoassay transformed C-peptide from a duckling into a swan. Diabetologia 2012; 55: 865-869.
83. Johnson JL, Duick DS, Chui MA, Aldasouqi SA. Identifying prediabetes using fasting insulin levels. Endocr Pract 2010; 16: 47-52.
84. Dankner R, Shanik MH, Keinan-Boker L, Cohen C, Chetrit A. Effect of elevated basal insulin on cancer incidence, and on mortality in cancer incident patients: the Israel Glucose Intolerance, Obesity and Hypertension (GOH) 29-year follow-up study. Diabetes Care 2012; 35: 1538-1543.
85. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 1990; 113: 909-915.
86. Weyer C, Hanson RL, Tataranni PA, Bogardus C, Pratley RE. A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia. Diabetes 2000; 49: 2094-2101.
87. Rahbar S, Blumenfeld O, Ranney HM. Studies of an unusual hemoglobin in patients with diabetes mellitus. Biochem Biophys Res Commun 1969; 36: 838-843.
88. Rahbar S. The discovery of glycated hemoglobin: a major event in the study of nonenzymatic chemistry in biological systems. Ann N Y Acad Sci 2005; 1043: 9-19.
89. 1c test results. Available from http://www.ngsp.org/factors.asp